A short overview history of the development, use, and specific characteristics of the most common targeted radiopharmaceuticals in use today, like Pluvicto, with much content focused on PCa. Very good article with a lot of development history most of us probably unaware of. The following paragraphs are the first in the much longer article:
* * *
On a Wednesday morning in late January 1896, at a small light bulb factory in Chicago, a middle-aged woman named Rose Lee found herself at the heart of a groundbreaking medical endeavor. With an X-ray tube positioned above the tumor in her left breast, Lee was treated with a torrent of high-energy particles that penetrated into the malignant mass.
“And so,” as her treating clinician later wrote, “without the blaring of trumpets or the beating of drums, X-ray therapy was born.”
Radiation therapy has come a long way since those early beginnings. The discovery of radium and other radioactive metals opened the doors to administering higher doses of radiation to target cancers located deeper within the body. The introduction of proton therapy later made it possible to precisely guide radiation beams to tumors, thus reducing damage to surrounding healthy tissues — a degree of accuracy that was further refined through improvements in medical physics, computer technologies and state-of-the-art imaging techniques.
But it wasn’t until the new millennium, with the arrival of targeted radiopharmaceuticals, that the field achieved a new level of molecular precision. These agents, akin to heat-seeking missiles programmed to hunt down cancer, journey through the bloodstream to deliver their radioactive warheads directly at the tumor site.
* * *
The full article can be found here:
Radioactive drugs strike cancer with precision - The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects, Knowable Magazine, By Elie Dolgin, 06.13.2024
knowablemagazine.org/conten...
* * *
As npfisherman has said many times . . . "The Science Is Coming"
Let's all of us try to Stay S&W while we wait for it to arrive.
Ciao - cujoe
After Radiation Therapy 
Nitric Oxide -- slows prostate cancer progression and PSA doubling time.
